Ametek (AME)

NYSEIndustrialsElectrical Equipment & PartsSnapshot 2026-10-15

$248.17-0.14%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Ametek’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+1.8%

+10% or more+5%0%−5%−10% or less

9.24 → 9.40 EPS · FY ending Dec 31, 2027 · 9 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 9; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

4 key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Quarterly dividend at least $0.34 per share	The company raised its quarterly dividend to $0.34 per share.	Intact	Dividend falls below $0.31 per share quarterly	Required source inputs unavailable Cannot calculate Dividend per share from the available matching source inputs. Missing inputs are not treated as zero. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Adjusted EPS reaches at least $8.14 in 2026	A primary condition in Ametek's published investment case. The stated target is >=8.14 USD per share.	Recovered	EPS falls below $7.06 in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue growth near 7.6% per year	A primary condition in Ametek's published investment case. The stated target is >=7.6% YoY.	Improving	Revenue growth falls below 5% YoY	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Complete strategic acquisitions to grow portfolio	A supporting condition in Ametek's published investment case. The stated target is Complete multiple strategic acquisitions in 2026.	Intact	No strategic acquisitions completed in FY26	2 acquisitions completed vs 0 trip condition 8-K filings confirm completion of First Aviation (May 26) and Indicor Instrumentation (Aug 26) acquisitions. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$9.40

$8.81 → $9.40 · observed estimates

FY2027 revenue$9.91B

$8.49B → $9.91B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$8.81	$8,491,026,350	16 / 16
2026-07-25	$8.81	$8,491,026,350	16 / 16
2026-07-26	$8.81	$8,491,026,350	16 / 16
2026-07-27	$8.84	$8,486,424,790	12 / 13
2026-07-28	$8.81	$8,491,026,350	16 / 16
2026-07-29	$8.81	$8,491,026,350	16 / 16
2026-07-30	$8.81	$8,491,026,350	16 / 16
2026-07-31	$8.81	$8,491,026,350	16 / 16
2026-08-01	$8.84	$8,486,424,790	12 / 13
2026-08-02	$8.81	$8,491,026,350	16 / 16
2026-08-03	$8.81	$8,491,026,350	16 / 16
2026-08-04	$8.81	$8,491,026,350	16 / 16
2026-08-05	$8.81	$8,491,026,350	16 / 16
2026-08-06	$8.81	$8,491,026,350	16 / 16
2026-08-07	$9.10	$8,683,387,185	12 / 13
2026-08-08	$9.10	$8,683,387,185	12 / 13
2026-08-09	$8.98	$8,683,346,360	15 / 15
2026-08-10	$8.98	$8,683,346,360	15 / 15
2026-08-11	$8.98	$8,683,346,360	15 / 15
2026-08-12	$8.98	$8,683,346,360	15 / 15
2026-08-13	$8.98	$8,683,346,360	15 / 15
2026-08-14	$9.10	$8,683,387,185	12 / 13
2026-08-15	$9.10	$8,683,387,185	11 / 12
2026-08-16	$9.10	$8,683,387,185	11 / 12
2026-08-17	$9.10	$8,683,387,185	11 / 12
2026-08-18	$9.10	$8,683,387,185	11 / 12
2026-08-19	$9.10	$8,683,387,185	11 / 12
2026-08-20	$9.10	$8,683,387,185	11 / 12
2026-08-21	$9.11	$8,696,053,852	11 / 12
2026-08-22	$9.11	$8,696,053,852	11 / 12
2026-08-23	$9.11	$8,696,053,852	11 / 12
2026-08-24	$9.11	$8,696,053,852	11 / 12
2026-08-25	$9.13	$8,715,696,251	11 / 12
2026-08-26	$9.13	$8,715,669,585	11 / 12
2026-08-27	$9.13	$8,715,669,585	11 / 12
2026-08-28	$9.13	$8,715,669,585	11 / 12
2026-08-29	$9.16	$8,721,931,698	11 / 12
2026-08-30	$9.16	$8,721,931,698	11 / 12
2026-08-31	$9.16	$8,721,931,698	11 / 12
2026-09-01	$9.16	$8,721,931,698	10 / 9
2026-09-02	$9.16	$8,721,931,698	10 / 9
2026-09-03	$9.17	$8,720,341,828	7 / 6
2026-09-04	$9.17	$8,720,341,828	7 / 6
2026-09-05	$9.17	$8,720,341,828	7 / 5
2026-09-06	$9.17	$8,720,341,828	7 / 5
2026-09-07	$9.17	$8,720,341,828	7 / 5
2026-09-08	$9.17	$8,720,341,828	7 / 5
2026-09-09	$9.21	$8,742,639,527	7 / 6
2026-09-10	$9.21	$8,742,639,527	7 / 6
2026-09-11	$9.21	$8,742,639,527	7 / 6
2026-09-12	$9.24	$8,739,370,393	7 / 6
2026-09-13	$9.24	$8,739,370,393	7 / 6
2026-09-14	$9.24	$8,739,370,393	8 / 7
2026-09-15	$9.24	$8,739,370,393	8 / 7
2026-09-16	$9.24	$8,739,370,393	8 / 7
2026-09-17	$9.24	$8,739,370,393	8 / 7
2026-09-18	$9.24	$8,739,370,393	8 / 7
2026-09-19	$9.23	$8,739,370,393	8 / 7
2026-09-20	$9.23	$8,739,370,393	8 / 7
2026-09-21	$9.23	$8,739,370,393	8 / 7
2026-09-22	$9.23	$8,739,370,393	8 / 7
2026-09-23	$9.23	$8,739,370,393	8 / 7
2026-09-24	$9.23	$8,739,370,393	8 / 7
2026-09-25	$9.23	$8,739,370,393	8 / 7
2026-09-26	$9.27	$8,728,888,268	8 / 7
2026-09-27	$9.27	$8,728,888,268	8 / 7
2026-09-28	$9.27	$8,728,888,268	8 / 7
2026-09-29	$9.27	$8,728,888,268	8 / 7
2026-09-30	$9.27	$8,728,888,268	8 / 7
2026-10-01	$9.32	$8,725,431,409	9 / 8
2026-10-02	$9.32	$8,725,431,409	9 / 8
2026-10-03	$9.32	$8,725,431,409	7 / 8
2026-10-04	$9.34	$8,719,364,086	7 / 9
2026-10-05	$9.34	$8,719,364,086	7 / 9
2026-10-06	$9.34	$9,929,491,440	7 / 9
2026-10-07	$9.34	$9,925,945,985	8 / 9
2026-10-08	$9.34	$9,925,945,985	7 / 9
2026-10-09	$9.36	$9,925,945,985	8 / 10
2026-10-10	$9.38	$9,922,780,569	9 / 10
2026-10-11	$9.38	$9,922,780,569	9 / 10
2026-10-12	$9.38	$9,922,780,569	9 / 10
2026-10-13	$9.38	$9,922,780,569	9 / 10
2026-10-14	$9.40	$9,906,489,756	9 / 11
2026-10-15	$9.40	$9,906,489,756	9 / 11

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	14	6	1
2026-06-01	14	7	0
2026-07-01	14	6	0
2026-08-01	14	6	1
2026-09-01	14	6	1
2026-10-01	14	5	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 14 Buy / Strong Buy · 5 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades2 maintains

Recent actions · Sep 16–Oct 15 · 2 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Morgan StanleyOct 9 · prior Jul 10

$245.00 → $275.00+12.2%

D.A. DavidsonOct 7

$285.00New observation · no comparable prior

$0$156.75$313.50

1 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Quarterly dividend at least $0.34 per shareRequired source inputs unavailable
Adjusted EPS reaches at least $8.14 in 2026Direct metric needs a verified mapping
Revenue growth near 7.6% per yearDirect metric needs a verified mapping

Next proof point

Oct 29, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.9%Typical daily move · historical

Downside history

-13.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Ametek outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

AME represents a durable compounder with a focus on consistent earnings growth and strategic acquisitions. The current thesis is intact, supported by management's commitment to double-digit EPS growth and shareholder returns.

What's priced into Ametek

The market currently views AME as expensive compared to its peers, with a slight expectations gap indicating that some growth is already anticipated. The valuation reflects a premium, suggesting that investors are expecting continued strong performance.

What the fundamentals likely do

Fundamentals are likely to remain stable, as management is on track with its priorities, including revenue growth and strategic acquisitions. However, there is a low probability of missing earnings expectations, although the industry has a history of higher miss rates.

What Ametek hinges on

The future performance of AME hinges on the guidance provided in the next earnings call and the performance of sector bellwethers like ETN, VRT, and BE. Positive or negative shifts in these companies' earnings could significantly impact AME's trajectory.